天津中合基因科技有限公司(中合基因)于2022年成立，是国内首家以第三代生物酶促基因合成技术及装备开发、生产、销售为核心的企业。公司致力于成为合成生物学底层核心装备的开创者、全球领先的长链基因生物合成仪供应商。中合基因以“酶促DNA合成技术”为基础，现已成功研制第一代oligo生物合成仪原理样机、Kb级基因拼接仪原理样机，相关技术已获3项专利认证、5项专利受理审查。公司以合成基因，改造世界为愿景，打造桌面式一体化Kb级基因合成仪，开拓新型市场应用模式，广泛运用于医疗诊断、药物研发、基础科研服务等领域。

Tianjin Zhonghe Gene Technology Co., Ltd. (Zhonghe Gene) was established in 2022 and is the first enterprise in China with the development, production and sales of third-generation biological enzymatic gene synthesis technology and equipment as the core. The company is committed to becoming the pioneer of the underlying core equipment of synthetic biology and the world's leading supplier of long-chain gene biosynthesis instruments. Based on "enzymatic DNA synthesis technology", Zhonghe Gene has successfully developed the principle prototype of the first-generation oligo biosynthesizer and the principle prototype of Kb-level gene splicing instrument, and the related technology has obtained 3 patent certifications and 5 patent acceptance and examination. With the vision of synthesizing genes and transforming the world, the company creates a desktop integrated Kb gene synthesizer, develops new market application models, and is widely used in medical diagnosis, drug research and development, basic scientific research services and other fields.